Alexandria Pharmaceuticals
- 311.00 EGP
- -6.85
- -2.16%
Alexandria Pharmaceuticals and Chemical Industries Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 311.00 |
| Prev. Close | 317.850 |
| Day Range | 307.02 - 317.00 |
| 52WK range | |
| Turnover (M EGP) | 0.01 |
| Volume (M) | 0.00 |
| Number of Trades | 6 |
| Market Cap (M EGP) | 1,585.85 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 0.00 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Alexandria Pharmaceuticals’ profits retreat 25% in...
Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries posted an annual decrease of 25.24% in net profits after tax during the period...
Alexandria Pharmaceuticals profits fall 22.5% in 7M-21/22
Cairo – Mubasher: The net profits after tax of Alexandria Pharmaceuticals and Chemical Industries declined by 22.50% year-on-year (YoY) during the...
Alexandria Pharmaceuticals posts 27% lower profits...
Cairo – Mubasher: The net profits of Alexandria Pharmaceuticals and Chemical Industries has reported a 27.25% year-on-year (YoY) decrease...
Alexandria Pharmaceuticals reports 34% lower profits...
Cairo – Mubasher: The net profits of Alexandria Pharmaceuticals and Chemical Industries declined by 34.1% to EGP 35.72 million...
Alexandria Pharmaceuticals targets EGP 129m net profits...
Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries plans to achieve net profits after tax worth EGP 129 million during fiscal year...
